Cigarette Smoking and Age-Related Macular Degeneration in the EUREYE Study

Ophthalmology

Volumn 114, Issue 6, 2007, Pages 1157-1163

  Chakravarthy, U ^a   Augood, C ^b   Bentham, G C ^c   de Jong, P T V M ^d   Rahu, M ^e   Seland, J ^f   Soubrane, G ^g   Tomazzoli, L ^h   Topouzis, F ⁱ   Vingerling, J R ^j   Vioque, J ^k   Young, I S ^a   Fletcher, A E ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^e NATIONAL INSTITUTE FOR HEALTH DEVELOPMENT   (Estonia)

^f UNIVERSITY OF BERGEN   (Norway)

^g UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^h UNIVERSITY OF VERONA   (Italy)

ⁱ ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^j ERASMUS MEDICAL CENTER   (Netherlands)

^k MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CIGARETTE SMOKING; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; EUROPE; EYE EXAMINATION; HUMAN; HUMAN EXPERIMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SMOKING HABIT;

AGED; CHOROIDAL NEOVASCULARIZATION; CROSS-SECTIONAL STUDIES; ENVIRONMENT; EUROPE; FEMALE; HUMANS; LIFE STYLE; MACULAR DEGENERATION; MALE; ODDS RATIO; PHOTOGRAPHY; QUESTIONNAIRES; RISK FACTORS; SMOKING; SMOKING CESSATION; TOBACCO SMOKE POLLUTION;

EID: 34249675425     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.09.022     Document Type: Article

References (33)

1. Resnikoff S., Pascolini D., Etya'ale D., et al. Global data on visual impairment in the year 2002. Bull World Health Organ 82 (2004) 844-851
2. Owen C.G., Fletcher A.E., Donoghue M., and Rudnicka A.R. How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?. Br J Ophthalmol 87 (2003) 312-317
3. Klein R., Davis M.D., Magli Y.L., et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 98 (1991) 1128-1134
4. Smith W., Mitchell P., and Leeder S.R. Smoking and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 114 (1996) 1518-1523
5. Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration: a case-control study in the age-related eye disease study. Age-Related Eye Disease Study report number 3. Ophthalmology 107 (2000) 2224-2232
6. Klein R., Klein B.E., Linton K.L., and DeMets D.L. The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol 137 (1993) 190-200
7. McCarty C.A., Mukesh B.N., Fu C.L., et al. Risk factors for age-related maculopathy: the Visual Impairment Project. Arch Ophthalmol 119 (2001) 1455-1462
8. Tomany S.C., Wang J.J., Van Leeuwen R., et al. Risk factors for incident age-related macular degeneration. Pooled findings from 3 continents. Ophthalmology 111 (2004) 1280-1287
9. Thornton J., Edwards R., Mitchell P., et al. Smoking and age-related macular degeneration: a review of association. Eye 19 (2005) 935-944
10. Augood C., Fletcher A., Bentham G., et al. Methods for a population-based study of the prevalence of and risk factors for age-related maculopathy and macular degeneration in elderly European populations: the EUREYE study. Ophthalmic Epidemiol 11 (2004) 117-129
11. Clarke R., Breeze E., Sherliker P., et al. Design, objectives, and lessons from a pilot 25 year follow up re-survey of survivors in the Whitehall study of London Civil Servants. J Epidemiol Community Health 52 (1998) 364-369
12. Bird A.C., Bressler N.M., Bressler S.B., et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. Surv Ophthalmol 39 (1995) 367-374
13. van Leeuwen R., Klaver C.C., Vingerling J.R., et al. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. Arch Ophthalmol 121 (2003) 519-526
14. Augood C.A., Vingerling J.R., de Jong P.T., et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol 124 (2006) 529-535
15. Smith W., Assink J., Klein R., et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 108 (2001) 697-704
16. Eye Disease Case-Control Study Group. Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 110 (1992) 1701-1708
17. Delcourt C., Diaz J.L., Ponton-Sanchez A., et al. Smoking and age-related macular degeneration: the POLA Study. Arch Ophthalmol 116 (1998) 1031-1035
18. Evans J.R., Fletcher A.E., and Wormald R.P. 28,000 cases of age related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br J Ophthalmol 89 (2005) 550-553
19. Seddon J.M., Willett W.C., Speizer F.E., and Hankinson S.E. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 276 (1996) 1141-1146
20. Christen W.G., Glynn R.J., Manson J.E., et al. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA 276 (1996) 1147-1151
21. Age-Related Eye Disease Study Research Group. Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS). AREDS report no. 19. Ophthalmology 112 (2005) 533-539
22. Patton W.P., Routledge M.N., Jones G.D., et al. Retinal pigment epithelial cell DNA is damaged by exposure to benzo[a]pyrene, a constituent of cigarette smoke. Exp Eye Res 74 (2002) 513-522
23. Suner I.J., Espinosa-Heidmann D.G., Marin-Castano M.E., et al. Nicotine increases size and severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 45 (2004) 311-317
24. Bok D. Evidence for an inflammatory process in age-related macular degeneration gains new support. Proc Natl Acad Sci U S A 102 (2005) 7053-7054
25. Hageman G.S., Anderson D.H., Johnson L.V., et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102 (2005) 7227-7232
26. Zareparsi S., Branham K.E., Li M., et al. Strong association of the Y402H variant in complement factor H at 1q32 with susceptibility to age-related macular degeneration. Am J Hum Genet 77 (2005) 149-153
27. Edwards A.O., Ritter III R., Abel K.J., et al. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
28. Haines J.L., Hauser M.A., Schmidt S., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421
29. Klein R.J., Zeiss C., Chew E.Y., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389
30. Kew R.R., Ghebrehiwet B., and Janoff A. Cigarette smoke can activate the alternative pathway of complement in vitro by modifying the third component of complement. J Clin Invest 75 (1985) 1000-1007
31. Maresh J.G., Xu H., Jiang N., et al. Tobacco smoke dysregulates endothelial vasoregulatory transcripts in vivo. Physiol Genomics 21 (2005) 308-313
32. Schmidt S., Hauser M.A., Scott W.K., et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 78 (2006) 852-864
33. Cavelaars A.E., Kunst A.E., Geurts J.J., et al. Educational differences in smoking: international comparison. BMJ 320 (2000) 1102-1107